» Articles » PMID: 28444861

LncRNA MALAT1 is Dysregulated in Diabetic Nephropathy and Involved in High Glucose-induced Podocyte Injury Via Its Interplay with β-catenin

Overview
Journal J Cell Mol Med
Date 2017 Apr 27
PMID 28444861
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis associated lung adenocarcinoma transcript 1(MALAT1) is a long non-coding RNA, broadly expressed in mammalian tissues including kidney and up-regulated in a variety of cancer cells. To date, its functions in podocytes are largely unknown. β-catenin is a key mediator in the canonical and non-canonical Wnt signalling pathway; its aberrant expression promotes podocyte malfunction and albuminuria, and contributes to kidney fibrosis. In this study, we found that MALAT1 levels were increased in kidney cortices from C57BL/6 mice with streptozocin (STZ)-induced diabetic nephropathy, and dynamically regulated in cultured mouse podocytes stimulated with high glucose, which showed a trend from rise to decline. The decline of MALAT1 levels was accompanied with β-catenin translocation to the nuclei and enhanced expression of serine/arginine splicing factor 1 (SRSF1), a MALAT1 RNA-binding protein. Further we showed early interference with MALAT1 siRNA partially restored podocytes function and prohibited β-catenin nuclear accumulation and SRSF1 overexpression. Intriguingly, we showed that β-catenin was involved in MALAT1 transcription by binding to the promotor region of MALAT1; β-catenin knock-down also decreased MALAT1 levels, suggesting a novel feedback regulation between MALAT1 and β-catenin. Notably, β-catenin deletion had limited effects on SRSF1 expression, demonstrating β-catenin might serve as a downstream signal of SRSF1. These findings provided evidence for a pivotal role of MALAT1 in diabetic nephropathy and high glucose-induced podocyte damage.

Citing Articles

Stress-Related LncRNAs and Their Roles in Diabetes and Diabetic Complications.

Li L, Wu Y, Yang J Int J Mol Sci. 2025; 26(5).

PMID: 40076814 PMC: 11900361. DOI: 10.3390/ijms26052194.


Regulation of energy metabolism by non-coding RNAs in livestock species: a review.

Hassan F, Safdar M, Younus M, Arain M J Comp Physiol B. 2024; 195(1):1-12.

PMID: 39638953 DOI: 10.1007/s00360-024-01596-8.


Focus on podocytes: diabetic kidney disease and renal fibrosis - a global bibliometric analysis (2000-2024).

An D, Tan J, Lu Y, Wen Z, Bao Y, Yao Z Front Pharmacol. 2024; 15:1454586.

PMID: 39619610 PMC: 11605685. DOI: 10.3389/fphar.2024.1454586.


LncRNA PVT1 induces mitochondrial dysfunction of podocytes via TRIM56 in diabetic kidney disease.

Lv Z, Wang Z, Hu J, Su H, Liu B, Lang Y Cell Death Dis. 2024; 15(9):697.

PMID: 39349450 PMC: 11442824. DOI: 10.1038/s41419-024-07107-5.


LncRNA SNHG14 silencing attenuates the progression of diabetic nephropathy via the miR-30e-5p/SOX4 axis.

Wang Y, Yang J, Wu C, Guo Y, Ding Y, Zou X J Diabetes. 2024; 16(6):e13565.

PMID: 38751373 PMC: 11096814. DOI: 10.1111/1753-0407.13565.


References
1.
Teixeira V, Blattner S, Li M, Anders H, Cohen C, Edenhofer I . Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int. 2005; 67(2):514-23. DOI: 10.1111/j.1523-1755.2005.67108.x. View

2.
Voskas D, Ling L, Woodgett J . Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?. F1000 Biol Rep. 2011; 2:82. PMC: 3026644. DOI: 10.3410/B2-82. View

3.
Oltean S, Gammons M, Hulse R, Hamdollah-Zadeh M, Mavrou A, Donaldson L . SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases. Biochem Soc Trans. 2012; 40(4):831-5. DOI: 10.1042/BST20120051. View

4.
Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, Li H . Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch. 2006; 448(4):485-92. DOI: 10.1007/s00428-005-0134-9. View

5.
Bernard D, Prasanth K, Tripathi V, Colasse S, Nakamura T, Xuan Z . A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010; 29(18):3082-93. PMC: 2944070. DOI: 10.1038/emboj.2010.199. View